Biotech stocks surged in 2025, driven by FDA approvals, M&A activity, and rising longevity investment. Explore key trends, top-performing sectors, and what’s next for biotech investors.
Original Image Link
Source:www.newsweek.com
Original Image Link
Source:www.newsweek.com
Posted: 2026-03-22 05:30:00

















